Why the study?
Does heparin coating of metallic coronary stents reduce thrombogenicity and improve late vessel patency and neointimal hyperplasia in a porcine coronary model?
Does heparin coating of metallic coronary stents reduce thrombogenicity and improve late vessel patency and neointimal hyperplasia in a porcine coronary model?
Heparin coating of coronary stents reduces thrombogenicity but fails to prevent late neointimal hyperplasia in a porcine model.
Challenges translation of reduced thrombogenicity to late patency benefits; hypothesis-generating for coated stent strategies.
Heparin coating of metallic coronary stents decreases their thrombogenicity but does not improve late vessel patency and neointimal hyperplasia at follow-up in a porcine coronary model.
No takes yet. Share an insight, caveat, or question.
Scheerder et al. (1997) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: